Seattle Genetics (SGEN) Tops Q3 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Wall Street sinks as bond yields rise, Walmart results disappoint
Cantor Fitzgerald Upgrades Seattle Genetics (SGEN) to Hold
October 31, 2014 7:45 AM EDTCantor Fitzgerald upgraded Seattle Genetics (NASDAQ: SGEN) from Sell to Hold with a price target of $35.00 (from $29.00).
Analyst Mara Goldstein said, "Following the release of 3Q:14 EPS, we are raising our rating to HOLD from SELL and our PT to $35 from $29. This is... More
